Evolution of CD8+ T cell immunity and viral escape following acute HIV-1 infection

被引:96
作者
Cao, JH
McNevin, J
Malhotra, U
McElrath, MJ
机构
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, Program Infect Dis, Seattle, WA 98109 USA
[2] Univ Washington, Dept Med, Seattle, WA 98195 USA
[3] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA
关键词
D O I
10.4049/jimmunol.171.7.3837
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Induction of HIV-1-specific CD8(+) T cells during acute infection is associated with a decline in viremia. The role CD8(+) effectors play in subsequently establishing viral set point remains unclear. To address this, we focused on two acutely infected patients with the same initial Tat-specific CD8(+) response, analyzing their CD8(+) T cell responses longitudinally in conjunction with viral load and sequence evolution. In one patient initiating treatment during acute infection, the frequencies of Tat-specific CD8(+) T cells gradually diminished but persisted, and the Tat epitope sequence was unaltered. By contrast, in the second patient who declined treatment, the Tat-specific CD8(+) T cells disappeared below detection, in conjunction with Gag-specific CD4(+) T cell loss, as plasma viremia reached a set point. This coincided with the emergence of an escape variant within the Tat epitope and an additional Vpr epitope. New CD8(+) T cell responses emerged but with no further associated decline in viremia. These findings indicate that, in the absence of treatment, the initial CD8(+) T cell responses have the greatest impact on reducing viremia, and that later, continuously evolving responses are less efficient in further reducing viral load. The results also suggest that T cell help may contribute to the antiviral efficiency of the acute CD8(+) T cell response.
引用
收藏
页码:3837 / 3846
页数:10
相关论文
共 49 条
[1]   The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals [J].
Addo, MM ;
Altfeld, M ;
Rosenberg, ES ;
Eldridge, RL ;
Philips, MN ;
Habeeb, K ;
Khatri, A ;
Brander, C ;
Robbins, GK ;
Mazzara, GP ;
Goulder, PJR ;
Walker, BD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) :1781-1786
[2]   Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection [J].
Alexander, L ;
Weiskopf, E ;
Greenough, TC ;
Gaddis, NC ;
Auerbach, MR ;
Malim, MH ;
O'Brien, SJ ;
Walker, BD ;
Sullivan, JL ;
Desrosiers, RC .
JOURNAL OF VIROLOGY, 2000, 74 (09) :4361-4376
[3]   Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia [J].
Allen, TM ;
O'Connor, DH ;
Jing, PC ;
Dzuris, JL ;
Mothé, BR ;
Vogel, TU ;
Dunphy, E ;
Liebl, ME ;
Emerson, C ;
Wilson, N ;
Kunstman, KJ ;
Wang, XC ;
Allison, DB ;
Hughes, AL ;
Desrosiers, RC ;
Altman, JD ;
Wolinsky, SM ;
Sette, A ;
Watkins, DI .
NATURE, 2000, 407 (6802) :386-390
[4]   Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection [J].
Altfeld, M ;
Rosenberg, ES ;
Shankarappa, R ;
Mukherjee, JS ;
Hecht, FM ;
Eldridge, RL ;
Addo, MM ;
Poon, SH ;
Phillips, MN ;
Robbins, GK ;
Sax, PE ;
Boswell, S ;
Kahn, JO ;
Brander, C ;
Goulder, PJR ;
Levy, JA ;
Mullins, JI ;
Walker, BD .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) :169-180
[5]   Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS [J].
Berrey, MM ;
Schacker, T ;
Collier, AC ;
Shea, T ;
Brodie, SJ ;
Mayers, D ;
Coombs, R ;
Krieger, J ;
Chun, TW ;
Fauci, A ;
Self, SG ;
Corey, L .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (10) :1466-1475
[6]   EFFECTS OF HUMAN-IMMUNODEFICIENCY-VIRUS ON THE CELLULAR IMMUNE-RESPONSE TO EPSTEIN-BARR-VIRUS IN HOMOSEXUAL MEN - CHARACTERIZATION OF THE CYTOTOXIC RESPONSE AND LYMPHOKINE PRODUCTION [J].
BLUMBERG, RS ;
PARADIS, T ;
BYINGTON, R ;
HENLE, W ;
HIRSCH, MS ;
SCHOOLEY, RT .
JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (05) :877-890
[7]   Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus [J].
Borrow, P ;
Lewicki, H ;
Wei, XP ;
Horwitz, MS ;
Peffer, N ;
Meyers, H ;
Nelson, JA ;
Gairin, JE ;
Hahn, BH ;
Oldstone, MBA ;
Shaw, GM .
NATURE MEDICINE, 1997, 3 (02) :205-211
[8]   VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
BORROW, P ;
LEWICKI, H ;
HAHN, BH ;
SHAW, GM ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6103-6110
[9]   Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection [J].
Brander, C ;
Hartman, KE ;
Trocha, AK ;
Jones, NG ;
Johnson, RP ;
Korber, B ;
Wentworth, P ;
Buchbinder, SP ;
Wolinsky, S ;
Walker, BD ;
Kalams, SA .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (11) :2559-2566
[10]   COMPREHENSIVE, SEROLOGICALLY EQUIVALENT DNA TYPING FOR HLA-B BY PCR USING SEQUENCE-SPECIFIC PRIMERS (PCR-SSP) [J].
BUNCE, M ;
FANNING, GC ;
WELSH, KI .
TISSUE ANTIGENS, 1995, 45 (02) :81-90